Versions Compared

Old Version 41

changes.mady.by.user Kerry Robson

Saved on

compared with

New Version Current

changes.mady.by.user Alex Pearce

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Scope

Project

Scope 

This project team will create a users guide or White Paper with recommendations for analyses and displays associated with Hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents.



Project LeadsEmail

Melvin Munsaka

(

, AbbVie

)

melvin.munsaka@abbvie.com

Terry Walsh

(

, Astellas

Pharma)

terry.walsh@astellas.com

Katie Warren (

Nicola Newton, PHUSE Project Assistant

)

katie@phuse

nicky@phuse.global

 


Status
colourBlue
titleCurrent Status

Q12022
  • The group have started to draft their White Paper and is currently in progress.
    • Wide scope of examples have now been gathered.

    Q1 2024

    • FDA comments incorporated into the WP



    Objectives & Deliverables

    TimelinesDraft of the initial scope (
    Timelines 

    Finalise Stage 1

    )

    of draft White

    Paper Q22022Project MembersOrganisationAmelia PangSanofiCharles BeasleyMSNDarshan Bhatt Industry Eileen Navarro AlmarioFDAHongli LuMerckJohn MarciankAbbViePatrick HannonMMS Paul HayashiA2 Healthcare CorporationPreeti VenkataramanFDAShayamiEli LillySwarnalatha ReddyIndustryVeronical Pei YangFDA

    Paper

    		Q4 2023
    William Palo AbbVie